Literature DB >> 11703631

Diabetic nephropathy: prevention and treatment.

H H Parving1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11703631     DOI： 10.1046/j.1523-1755.2001.00020.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  39 in total

Review 1.  Clinical impact of albuminuria in diabetic nephropathy.

Authors:  Takashi Wada; Miho Shimizu; Tadashi Toyama; Akinori Hara; Shuichi Kaneko; Kengo Furuichi
Journal:  Clin Exp Nephrol       Date:  2011-08-10       Impact factor: 2.801

2.  Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.

Authors:  Tangli Xiao; Xu Guan; Ling Nie; Song Wang; Lei Sun; Ting He; Yunjian Huang; Jingbo Zhang; Ke Yang; Junping Wang; Jinghong Zhao
Journal:  Mol Cell Biochem       Date:  2014-05-22       Impact factor: 3.396

Review 3.  Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.

Authors:  Mark A Perazella; John F Setaro
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

Review 4.  Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update.

Authors:  K O Alsaad; A M Herzenberg
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

5.  Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy.

Authors:  Ailing Lu; Mi Miao; Trenton R Schoeb; Anupam Agarwal; Joanne E Murphy-Ullrich
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  Long non-coding RNA Hottip modulates high-glucose-induced inflammation and ECM accumulation through miR-455-3p/WNT2B in mouse mesangial cells.

Authors:  Xiang-Jun Zhu; Zhaung Gong; Shu-Juan Li; Hai-Ping Jia; Da-Lin Li
Journal:  Int J Clin Exp Pathol       Date:  2019-07-01

Review 7.  Appropriate drug therapy for improving outcomes in diabetic nephropathy.

Authors:  Robert D Toto
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

8.  Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Michel Chonchol; Lorenzo Bertolini; Stefano Rodella; Luciano Zenari; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

9.  Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy.

Authors:  N Pasko; F Toti; A Strakosha; E Thengjilli; A Shehu; T Dedej; A Ylli; N Thereska
Journal:  Hippokratia       Date:  2013-10       Impact factor: 0.471

10.  Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

Authors:  Kuo-Chu Chang; Kwan-Lih Hsu; Chuen-Den Tseng; Yue-Der Lin; Yi-Li Cho; Yung-Zu Tseng
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.